Zim Laboratories Ltd. | Small-cap | Healthcare
₹73.93
-1.54%
| Zim Laboratories Stock Comparison:
Zim Laboratories vs Sun PharmaceuticalZim Laboratories vs Divi's LaboratoriesZim Laboratories vs Sun Pharma AdvancedZim Laboratories vs Sequent ScientificZim Laboratories vs Gujarat ThemisZim Laboratories vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 717.6M
Gross Profit 417.5M 58.18%
Operating Income -6.0M -0.84%
Net Income -18.7M -2.61%
EPS (Diluted) ₹-0.38

Balance Sheet Metrics

Total Assets 4.7B
Total Liabilities 2.2B
Shareholders Equity 2.5B
Debt to Equity 0.87

Cash Flow Metrics

Operating Cash Flow -59.6M
Free Cash Flow -5.4M

Revenue & Profitability Trend

Zim Laboratories Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i3.6B3.6B3.9B3.3B2.9B
Cost of Goods Sold i1.7B1.7B2.0B1.6B1.6B
Gross Profit i1.9B1.8B1.9B1.7B1.3B
Gross Margin % i53.5%51.5%48.6%50.9%45.5%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i380.1M357.3M410.6M445.8M364.0M
Other Operating Expenses i411.7M422.0M375.4M297.8M216.1M
Total Operating Expenses i791.8M779.3M786.0M743.6M580.1M
Operating Income i267.0M267.7M352.6M250.9M247.2M
Operating Margin % i7.4%7.5%9.1%7.6%8.5%
Non-Operating Items
Interest Income i3.3M1.3M3.4M2.8M6.9M
Interest Expense i94.7M58.8M49.7M71.7M95.1M
Other Non-Operating Income-----
Pre-tax Income i180.1M236.4M353.6M210.4M102.3M
Income Tax i58.4M64.0M109.2M64.9M29.1M
Effective Tax Rate % i32.5%27.1%30.9%30.9%28.5%
Net Income i121.6M172.5M244.3M145.5M73.2M
Net Margin % i3.4%4.9%6.3%4.4%2.5%
Key Metrics
EBITDA i498.6M465.9M584.5M443.0M413.8M
EPS (Basic) i₹2.50₹3.54₹5.01₹2.99₹1.50
EPS (Diluted) i₹2.50₹3.54₹5.01₹2.99₹1.50
Basic Shares Outstanding i4872581448725814487258144872581448684108
Diluted Shares Outstanding i4872581448725814487258144872581448684108

Income Statement Trend

Zim Laboratories Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i19.5M96.0M64.2M34.2M13.9M
Short-term Investments i658.0K403.0K453.0K-167.7M
Accounts Receivable i1.1B1.0B952.5M895.2M722.5M
Inventory i864.7M812.6M537.1M752.8M543.5M
Other Current Assets5.5M3.3M6.7M3.9M469.2M
Total Current Assets i2.3B2.3B1.9B2.1B1.9B
Non-Current Assets
Property, Plant & Equipment i139.1M186.1M122.7M88.2M64.4M
Goodwill i325.1M228.3M142.6M106.9M121.3M
Intangible Assets i321.7M224.9M139.2M103.5M118.0M
Long-term Investments-----
Other Non-Current Assets38.5M113.6M117.9M-56.6M
Total Non-Current Assets i2.4B2.2B1.5B1.3B1.3B
Total Assets i4.7B4.5B3.4B3.4B3.2B
Liabilities
Current Liabilities
Accounts Payable i695.1M623.8M582.4M810.7M648.7M
Short-term Debt i753.1M730.8M363.6M336.7M603.2M
Current Portion of Long-term Debt-----
Other Current Liabilities5.9M710.0K236.0K430.0K188.0K
Total Current Liabilities i1.7B1.6B1.1B1.5B1.4B
Non-Current Liabilities
Long-term Debt i423.7M385.5M256.4M196.5M220.0M
Deferred Tax Liabilities i110.5M101.0M48.0M3.6M0
Other Non-Current Liabilities-----110.0K
Total Non-Current Liabilities i534.2M486.5M304.5M200.1M220.0M
Total Liabilities i2.2B2.1B1.4B1.7B1.6B
Equity
Common Stock i487.3M487.3M487.3M162.4M162.4M
Retained Earnings i1.7B1.6B1.4B1.2B1.0B
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i2.5B2.4B2.0B1.8B1.6B
Key Metrics
Total Debt i1.2B1.1B620.0M533.1M823.2M
Working Capital i649.4M682.2M801.6M662.3M497.2M

Balance Sheet Composition

Zim Laboratories Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i180.1M236.4M353.6M210.4M154.1M
Depreciation & Amortization i-----
Stock-Based Compensation i13.5M---0
Working Capital Changes i-103.6M-346.9M242.7M-229.3M-108.7M
Operating Cash Flow i201.6M-43.1M649.6M60.8M149.4M
Investing Activities
Capital Expenditures i-400.7M-733.8M-366.5M-150.7M-64.7M
Acquisitions i----0
Investment Purchases i-3.6M-2.8M0--
Investment Sales i4.4M6.0M3.6M3.0M2.0M
Investing Cash Flow i-399.8M-730.6M-359.3M-144.7M-60.8M
Financing Activities
Share Repurchases i-----
Dividends Paid i-569.0K-493.0K-585.0K-1.7M-244.0K
Debt Issuance i246.2M281.5M183.5M270.7M191.7M
Debt Repayment i-153.2M-129.3M-154.7M-299.3M-234.9M
Financing Cash Flow i67.8M687.7M84.7M-238.2M-143.1M
Free Cash Flow i3.6M-576.4M15.0M339.8M253.7M
Net Change in Cash i-130.4M-86.0M375.1M-322.0M-54.6M

Cash Flow Trend

Zim Laboratories Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 38.11
Price to Book 1.43
Price to Sales 0.98
PEG Ratio -0.12

Profitability Ratios

Profit Margin 2.55%
Operating Margin -0.84%
Return on Equity 4.82%
Return on Assets 2.58%

Financial Health

Current Ratio 1.39
Debt to Equity 46.70
Beta 0.41

Per Share Data

EPS (TTM) ₹1.94
Book Value per Share ₹51.77
Revenue per Share ₹75.96

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
zimlab3.6B38.111.434.82%2.55%46.70
Sun Pharmaceutical 3.9T38.005.4715.08%19.29%3.26
Divi's Laboratories 1.6T70.8710.9114.64%23.89%0.03
Sun Pharma Advanced 47.4B-13.85-21.83157.88%-53.22%-1.24
Sequent Scientific 44.4B155.796.302.84%1.85%62.47
Gujarat Themis 43.3B96.8917.3919.64%30.17%12.27

Financial data is updated regularly. All figures are in the company's reporting currency.